Form 8-K - Current report:
SEC Accession No. 0001493152-24-023096
Filing Date
2024-06-07
Accepted
2024-06-07 16:05:32
Documents
13
Period of Report
2024-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41817
  Complete submission text file 0001493152-24-023096.txt   213537

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE impb-20240606.xsd EX-101.SCH 3036
3 XBRL LABEL FILE impb-20240606_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE impb-20240606_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3535
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-253037 | Film No.: 241029307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)